Reader Remarks on:

The HORIZON Study: Bisphosphonates for Patients on Corticosteroids

how about pediatric patients
pediatric patients
Potential adverse effect of zelodronic acid

how about pediatric patients

TL Lee, 10 May 2009 10:58 PM EST

Competing interests: None declared

what is your recommendation in pediatrics patients receiving high dose corticosteroid?

pediatric patients

Jeffrey Callen, University of Louisville; Deputy and Feature Editor, Journal Watch Dermatology, 12 May 2009 4:05 PM EST

Competing interests: None declared

Bone loss is a potential problem for these patients as well, but even more of an issue is the stunting of growth. The bisphosphonates are not approved for use in children, therefore you should discuss their use carefully with the patient's primary provider and assess the risks before prescribing.

Potential adverse effect of zelodronic acid

FC Payne, 1 Jan 2010 11:35 PM EST

Competing interests: None declared

I think I recall that zelodronic acid has been more frequently used in the treatment of osteoporosis in cancer patients than bisphosphonates. Jaw bone necrosis has occured, I recall, much more frequently in the zelodronic/cancer population than the bisphpsphonate/ cancer-free population.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?